The aims of the current study were to determine whether children with the 6 different APOE e genotypes show differences in gray matter maturation, particularly for those with e4 and e2 alleles, which are associated with poorer outcomes in many neurologic disorders.
APOE e2 also may affect brain variably. The e2 carriers were less likely to develop clinical dementia 15, 16 and had greater cognitive reserve, 17 since APOE e2 may be neuroprotective. 17 However, e2 carriers also had more cortical amyloid plaques, 18 with elevated risks of cerebral amyloid angiopathy 17 and cortical infarctions. 2 Furthermore, children carrying e2 performed worse on visuospatial tasks 12 and had thicker temporal cortices 5 than non-e2 carriers, similar to adults carrying e2 with mild cognitive impairment or AD. 19 Because of potentially opposite influences of APOE e4 and APOE e2, prior studies typically evaluated homozygous or heterozygous e4 or e2 individuals, but frequently excluded e2e4 participants. 5, 20, 21 One study assessed all 6 APOE genotypes but only on IQ and academic achievements. 13 Therefore, we evaluated group differences across all 6 APOE e genotypes on gray matter morphometry and cognition in typically developing children. We hypothesized that children with different APOE e genotypes, especially e4 and e2 carriers (including e2e4), would show differential gray matter measures and cognitive function across the age span of childhood. METHODS Participants. A total of 1,493 typically developing children aged 3 to 20 years were enrolled in the Pediatric Imaging, Neurocognition, and Genetics (PING) Study (http://ping.chd. ucsd.edu) at 10 US academic institutions from September 2010 to August 2012. The PING Study was designed to crosssectionally investigate how genes influence brain maturation and cognitive measures across childhood. Children were enrolled from diverse ethnic groups and socioeconomic status (SES); detailed participant criteria were reported previously. 22 Specifically, the 1,187 children in the current study were excluded for any confounding neurologic or psychiatric disorders, history of head trauma, mental retardation, preterm birth (,36 weeks), prenatal drug exposure (daily maternal illicit drug use .1 trimester), or any MRI contraindications (including pregnancy).
Standard protocol approvals, registrations, and patient consents. All participants provided written assents (older than 7 years) or consents (18 years or older), and parental consents (3-17 years) , which along with the protocol were approved by each of the local institutional review boards for human subject studies.
Genotyping. Genomic DNA extracted from saliva was genotyped in 1,187 children for APOE e (rs429358 and rs7412) using the iPLEX Gold assay at the Sequenom MassARRAY genotyping platform (Sequenom, San Diego, CA). Final genotypes were called using the MassARRAY Type, version 4.0. Replication and quality-control procedures were described previously. 22 Genetic ancestry factor (GAF) was determined with the ADMIXTURE software (https://www.genetics.ucla.edu/software/admixture/) and the Illumina Human660W-Quad BeadChip for the 6 major continental populations (African, Central Asian, East Asian, European, Native American, and Oceanic) in each child.
Magnetic resonance imaging. Image acquisition and processing were detailed previously. 22 All scans were performed on 3-tesla scanners (9 Siemens, 2 General Electric, 2 Philips) using closely matched sequences. The protocol included 3-dimensional T1-weighted structural MRI (magnetization-prepared rapidacquisition gradient echo, 1.0 3 1.0 3 1.2 mm 3 , 8 minutes) and diffusion-tensor imaging (echo-planar imaging, 2.5-mm isotropic, b 5 1,000 s/mm 2 , 30 directions, 10 minutes) (http://ping.chd. ucsd.edu). Image processing included verification of protocol compliance and quality assurance. Automated morphometry using a modified FreeSurfer software was performed on the whole brain, and 7 subcortical and 20 cortical regions of interest (ROIs) from the standard FreeSurfer atlas were selected based on reported APOE e effects in children 5 and neonates, 6, 7 or patients with AD. 4 Fractional anisotropy (FA) (corrected for B 0 inhomogeneities) in the same 7 subcortical ROIs was also assessed, since FA in these regions often increases during neurodevelopment. 23 Statistical analyses. Statistical analyses were performed using the PING data portal (https://ping-dataportal.ucsd.edu). 22 Genotype and genotype-by-age effects on morphometry and FA, and their relationships with cognition, were assessed with a general additive model (GAM) in R program (http://www.rproject.or/). GAM is a multiple linear regression model including smooth functions of variables that are data driven. Each model used age as a smooth independent variable and included a linear term for genotype and a smooth age-by-genotype interaction. 22 GAMs used thin plate regression splines for the smoothing basis (using the bs 5 "ts" specification), with basis dimensions k 5 4 for main-effect smooth terms (e.g., age) and k 5 3 for smooth interaction terms (e.g., age-by-sex).
All models covaried for SES (highest parental education and household income), sex, GAF, and scanner device. Subcortical volumes were adjusted for intracranial volume but not for average cortical thickness and area. For vertex-wise analyses, significance maps were thresholded at 5% using the false-discovery rate to correct for multiple comparisons. ROI-based analyses were corrected for multiple comparisons using the Holm-Bonferroni sequential method, which controls the family-wise error rate, using a stepwise procedure to adjust for significance levels instead of p values, and is uniformly more powerful than the Bonferroni correction. 28 Pairwise post hoc analyses were explored for contrasts with group differences on the GAM. Two children with e2e2 were not included in group analyses but are described separately.
RESULTS Participant characteristics. The 1,187 children were aged 12.1 6 5.0 years; 569 were girls (table e-1 on the Neurology ® Web site at Neurology.org). The 5 APOE e allele groups were similar in sex proportion. The e2e2 children were the youngest and e2e3 children were the oldest; e3e3 was most common (61.78%), followed by e3e4 (21.8%), e2e3 (11.9%), e2e4 (2.6%), and e4e4 (1.75%), with e2e2 the rarest (0.17%). All genotype groups showed significant European GAF (60%-70%), except for e4e4 (35% European, but higher African ancestry than other groups). Parents/guardians of e4e4 children had the lowest household income, education, and occupation levels.
Subcortical volume differences across genotypes. The hippocampi differed across genotype groups (figure 1, A and B; table e-2). Independent of age, e3e4 children had the largest, while e2e4 children had the smallest hippocampi across groups (figure 1B). Hippocampal volumes increased linearly with age but differed by APOE e genotype, with an inverted U shape in e3e3 children (peaking at 13.2 years). The 2 children with e2e2 had relatively large hippocampi.
Genotype-by-age on subcortical FA. Age-dependent FA changes were evaluated in all subcortical structures (table e-2; figure 1 , B-F). In the right hippocampus, FAs in e4e4 children were lower at younger ages (younger than 7 years) but normalized thereafter, with no changes with age ( figure 1B) . As a group, e2e4 children had the highest FA, while the younger e2e2 child showed the lowest hippocampal FA. Conversely, in the left amygdala, younger children (,7 years) with e4e4, e2e4, and e2e3 had lower FA than e3e3 and e3e4 groups, whose FA was constant with age ( figure 1D ). The left thalamus FA increased with age in all children ( figure 1E ), but children younger than 7 years with e2e4 and e4e4 had lower FA, while children older than 12 years with e4e4 showed higher FA ( figure 1E ). For cortical thickness, the right isthmus cingulate showed age-dependent thinning, except for e4e4 children who showed no change with age ( figure 3C ). Conversely, temporal pole thickness was constant with age, except for e4e4 children who showed age-related increases, with thinner cortices in younger and thicker cortices in older individuals ( figure 3D ). Furthermore, since prior reports compared e4 carriers (e4e4, e4e3) with non-e4 carriers (e3e3, e2e3), 5, 29 we performed vertex-based, whole-brain analyses using the same grouping. Compared to non-e4 carriers, e4 carriers had nonsignificantly thicker left entorhinal cortex (figure 4A, yellow region), verified on ROI analyses (figure 4B), and nonsignificantly thinner dorsal postcentral and lateral temporal cortices (figure 4A, lighter blue). However, cortical thickness showed a trend for group differences on age-dependent measures in parahippocampal regions and the left postcentral and entorhinal cortices (figure 4C, yellow regions). ROI analyses verified group differences in age-dependent thinning in the left entorhinal cortex. Specifically, e4e4 children showed the steepest slope (r 5 20.66, p 5 0.02), with thicker cortices in younger children but thinner cortices in older children (.11 years; figure 4D ), as reported for adolescents. 5 APOE e genotypes and age on cognitive performance.
Age-by-genotype interactions were found on executive function, attention, and WM (figure 5, A-C) but not episodic memory. Compared to other genotype groups, younger e4e4 children had lower scores on executive function and WM, but similar or better performance after age 8 years ( figure 5, A and B ). On the attention task, younger e2e4 children performed worse than other genotype groups, but their scores normalized after age 10 years ( figure 5C ).
Relationships between brain morphometry and cognition.
After adjustments for sex, SES, and GAF, brain regions with age-related genotype variations also showed differential correlations with attention or WM. In the right superior parietal gyrus, e2e4 children differed from other groups; those with larger superior parietal gyral volumes had the lowest attention (r 5 20.58, p 5 0.001; figure 5D ) or WM scores (r 5 20.59, p 5 0.0005; figure 5E ). Similarly, across genotypes, e2e4 children with thicker cortices had the poorest attention (right isthmus cingulate: r 5 20.62, p 5 0.0002, figure 5F ; temporal pole: r 5 20.43, p 5 0.01, figure 5G ), while e4e4 children with thinner temporal poles had poorer attention (r 5 10.5, p 5 0.02; figure 5G ). All children with smaller hippocampal volumes had poorer WM performance, especially e4e4 children (r 5 10.48, p 5 0.03; figure 5H ).
DISCUSSION
The APOE e gene is polymorphic with 3 alleles, with e3 being the most common (approximately 78%), followed by e4 (14%) and e2 (8%). 15 Evaluating all 6 APOE e genotypes in a large cohort of typically developing children clarified the associations of heterozygous vs homozygous e2 and e4 on brain development. The major findings are as follows: (1) compared to other genotype groups, e4e4, e2e2, and e2e4 children had altered agerelated slopes in brain regions often affected in AD 30 ; (2) smaller hippocampal volumes in younger e2e4 children and lower hippocampal FA in younger e4e4 children mirror the smaller volumes and steeper age-dependent atrophy of the hippocampi in elderly e4 and/or e2 carriers 31 ; and (3) the younger e2e4 and e4e4 children with altered age-related changes in brain measures also showed poorer performance on attention or WM tasks. Children with the most common e3e3 genotype served as our reference group. These children showed typical age-related increases in hippocampal volumes 32 and the medial orbitofrontal and occipital cortical areas until early adolescence. 33 They also showed the typical age-dependent increase in thalamic FA, 23 reflecting ongoing myelination, but not age-related increases in hippocampal and amygdala FA, as reported in healthy children without genotype groupings. 23 Age-dependent decreases in parietal cortical volume and thinning of the isthmus likely reflect pruning of neuronal synapses and cell shrinkage. 33 Furthermore, our e3e3 children with thinner isthmus had similarly better performance in WM and attention. 34 The children with APOE e2e3 genotype had comparable brain morphometry and cognitive performance as e3e3 children. However, younger (,7 years) e2e3 children, like those with e2e4 or e4e4, had relatively lower FA in left amygdala, suggesting lesser microstructural integrity, such as lower cellular density or lesser myelination. Since the amygdala is involved in emotional processing, these children may have greater vulnerability to emotional problems. Lower amygdala FA was also found in infants whose mothers had greater prenatal depressive symptoms 35 ; hence, future studies should include maternal depressive symptoms as a covariate to determine whether these symptoms might account for the lower amygdala FA in younger e2e3 children.
Relative to e3e3 children, those with one e4 allele, specifically APOE e3e4, had larger hippocampi, occipital and frontal cortical areas, and thicker Cortical thickness differences between e4 carriers and non-e4 carriers
These analyses were performed using the same grouping as prior studies. 5 temporal poles, but similar cognitive functioning. These larger brain measures are consistent with an antagonistic pleiotropic effect of e4, similar to findings in middle-aged (51-59 years) heterozygous e4 carriers (primarily e3e4). 3, 10 Normal or thicker cortices in our e3e4 children contrast with prior findings of thinner left entorhinal and orbitofrontal cortices (92% e3e4 compared to e3e3 children). 5 However, larger cortical areas in our e3e4 children resemble larger parietal volumes in e3e4 infants (ages 8.5-14 months) 7 relative to e3e3 participants. Moreover, consistent with our results, prior studies found similar IQ or cognitive performance between e3e4 and e3e3 children. 5, 13 Despite the relatively normal hippocampal volumes, the younger e4e4 participants had the lowest FA in hippocampus, amygdala, and thalamus, suggesting slower development initially with lesser myelination or lower cellularity in these regions. These children also did not show typical age-dependent cortical thinning in posterior cingulate (isthmus) cortex, which suggests aberrant brain maturation, possibly due to reduced synaptic pruning. Such possible aberrant brain maturation with lesser cortical thinning was found in children with prenatal alcohol exposure and fetal alcohol syndrome, 36 although such children were excluded in the current study. Furthermore, e4e4 children showed agedependent thickening of the temporal pole, which along with the isthmus, is often affected in AD 30, 37 and in cognitively healthy e4 carriers, 30 who showed age-dependent increases in amyloid deposition. 18 
Figure 5
Cognitive performance in relation to age, brain volumes, or cortical thickness APOE e genotype-by-age interactions on executive function (A), attention (B), and WM (C). Children with larger right superior parietal gyral volumes had poorer attention scores (D) or WM scores (E) across all genotype groups, especially those with APOE e2e4. Similarly, those with thicker cortices in the isthmus cingulate cortical thickness (F) and temporal poles (G) had poorer attention and WM scores, especially children with APOE e2e4. In contrast, children with APOE e4e4 with thicker cortices had better attention and WM scores (F and G). All children with larger hippocampal volumes had higher WM scores (H), especially children homozygous for APOE e4 (H). *Data for the e2e2 children (black dots) are not included in the group analyses. ROI 5 region of interest; WM 5 working memory.
Younger e4e4 children showed the poorest executive function and WM among groups, even after SES adjustment, similar to school-age e4 carriers with AD family history. 14 The normal cognition of our older e4e4 children is consistent with prior findings in older e4e4 children 5, 13 and in young and middleaged adults. 10 The e4e4 children with smaller hippocampal volumes and thinner temporal pole had poorer WM and attention; these findings resemble the thinnest frontal cortices 29 in middle-aged e4e4 individuals without dementia, who showed the most rapid decline on mental arithmetic tasks requiring WM. 26 Hence, e4 homozygosity might slow maturation of the hippocampus and cortical thickness, which in turn might negatively affect WM and attention. Mirroring these findings, older individuals with e4 homozygosity had the highest prevalence for AD (50%-91%) 4, 15 and the greatest hippocampal and temporal lobe atrophy 30 among genotypes.
Unlike e3e4 children with the largest hippocampi, e2e4 children had the smallest hippocampi and orbitofrontal and occipital surface areas among groups and across ages. Therefore, e4 allele effects differ greatly when combined with e2 vs e3. Although the younger e2e4 children had larger parietal cortices and thicker posterior cingulate cortices, they had poorer attention and WM. These findings also mirror those in the 3 e2e4 oldest old (.90 years) among 89 participants, since all 3 met criteria for dementia but not neuropathology for AD. 38 While e2 carriers showed reduced cognitive decline, e2e4 is a risk genotype for AD across ethnicity. 15 Unfortunately, e2e4 participants are often excluded from studies because of potentially opposite effects of e4 and e2. 11, 12, 21, 38 In the e2e2 children, the relatively large hippocampi are similar to the case reports of e2e2 adults, 31 and the lower hippocampal FA in the younger child suggests less coherent fibers in the large hippocampi. They also had relatively higher thalamic FA, similar to findings in e2 heterozygous adults. 39 Our e2e2 children also had poorer attention and executive function, while e2e2 children in a prior study showed above-average IQ. 13 Furthermore, a 92-year-old e2e2 woman showed no cognitive deficits until her stroke, despite the postmortem finding of prominent AD neuropathology. 16 The relative preservation of cognition in aging e2e2 individuals may be due to ApoE e2's antioxidant, anti-inflammatory, and antiproteolytic effects. 17 However, these processes may not be relevant in the developing brain.
For comparison with the literature, we also evaluated all e4 carriers. Hippocampal volumes in e4 carriers ranged from smaller (e2e4) to no difference (e4e4) or slightly larger (e3e4) relative to e3e3 children. Similarly, cortical surface areas were smallest in e2e4 but largest in e3e4 or e4e4. Hence, combining all e4 carriers might have attenuated or abolished group differences compared to non-e4 carriers, [5] [6] [7] 12, 14, 40 and the larger parietal volumes in the youngest e2e4 children or the thinnest isthmus gyrus and temporal poles in the youngest e4e4 children might have been missed. In fact, our e4 carriers collectively had nonsignificantly thicker temporal lobes, contrasting with thinner entorhinal cortices in a prior study of healthy e4 children. 5 However, further analysis showed that e4e4 children had steeper age-dependent thinning in this region, leading to thinner entorhinal cortices in adolescents, similar to prior findings. 5 Moreover, our youngest e4 carriers performed poorer on WM than the non-e4 carriers, which resemble WM deficits in older healthy e4 carriers. 25 The age-dependent brain measures of e4e4 and e2e4 children often deviated from those in the other genotype groups. The youngest children with one of these genotypes had less mature brain structures and poorer cognitive function, but tended to normalize or exceed the other genotype groups during late adolescence. Prior studies of e4e4 and e2e4 young adults showed larger specific brain structures and better cognitive performance, whereas older adults showed poorer cognitive performance or less efficient neural networks relative to other genotype groups. 9,10 Incidentally, e2e4 participants have a low odds ratio of AD until age 50 years, but the highest odds at age 70 years, 15 while e4 homozygosity leads to earliest AD onset (approximately 68 years). 4 This study has several limitations. Despite this relatively large sample, the age-related brain measures may be biased by the cohort effect, driven by participants with these rare genotypes at the extremes of age range, in this cross-sectional study. Longitudinal follow-ups are needed to confirm the true developmental trajectories in the less prevalent e4 or e2 carriers. In addition, some younger children (,5 years) could not perform all NIH Toolbox tasks; future studies with more young children using ageappropriate assessments are needed. Lastly, although we covaried for GAF, ethnicity may influence the effects of e4 and e2 on brain and cognitive measures. 4, 15 However, repeating all the analyses only in children with .50% European ancestry yielded similar results (table e-4, figures e-1 to e-3). Future studies should include a larger sample of children with other ancestry and evaluate them separately.
This large sample of children validated and extended prior smaller studies that showed altered brain development in e4 carriers. The e4e4 and e2e4 carriers appear to show the strongest antagonistic pleiotropic effects, with negative influences on brain structures and cognition at younger age, mirroring those in elderly participants and patients with AD. Future studies of APOE e should evaluate each genotype separately, since brain development, and possibly brain aging and recovery, may vary substantially across specific e4 or e2 genotypes. Finally, studying APOE e polymorphism in young children may provide early indications of risk of future brain injuries and dementia. Given the urgent need to determine how early patients with AD should receive interventions or preventive treatments, a thorough understanding of how AD risk genes, such as APOE e4, might independently or interactively influence the brain across the ages, is needed.
